5 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
#SideEffects #Table ... #DecisionAid #Orals ... #DM2 #Diabetes ... #Endocrinology # ... Pharmacology #Management
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
risks, and therapy should ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... #diabetes #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... Patients should ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology
Taken from Dr Motov's work on a CERTA regime.
This is published in conjunction with the CERTA
and protocols should ... @Gas_Craic #Management ... #Pharmacology # ... NonOpioid #Opiate ... PainSyndromes #Pathways #Table
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
empiric treatment should ... Please refer to the table ... Guidelines for dosing ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology